Scientists Contribute to the Development of Potential Therapeutics for Toxic Shock Syndrome
U.S. Newswire, June, 2007
To: MEDICAL EDITORS
Contact: Virginia S. Bowditch of the Boston Biomedical Research Institute, 1-617-658-7711, Sullivan@bbri.org
WATERTOWN, Mass., June 28 /PRNewswire-USNewswire/ -- Published in this month's issue of the journal Nature Medicine, a collaborative team of scientists from the University of Illinois, the University of Minnesota Medical School and the Boston Biomedical Research Institute describe engineered proteins that completely neutralize the lethal activity of a bacterial superantigen in animal models. Their work holds great promise for the development of new therapeutics for toxic shock syndrome, a condition that is characterized by high fever and hypotension and can lead to multi-organ failure and death, and for which no treatment is currently...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Getting the global view: Nestle, led by Peter Brabeck-Letmathe, climbs to the #1 spot in this year's Best Companies for Leaders
